ACL.AX ASX
Australian Clinical Labs Limited
1W: +0.7%
1M: +3.0%
3M: +22.4%
YTD: +11.2%
1Y: +6.9%
3Y: +3.7%
5Y: -21.2%
A$2.81 ($1.96)
+0.02 (+0.72%)
Weekly Expected Move ±3.4%
A$3
A$3
A$3
A$3
A$3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#3
of 13
Medical - Diagnostics & Research
Technical Signal Map
4 Bullish
0 Neutral
9 Bearish
ACL.AX
$520M
Australian Clinical Labs Limited
BULLISH
+43
BDX.AX
$30M
BCAL Diagnostics Limited
BULLISH
+35
GSS.AX
$20M
Genetic Signatures Limited
LEAN BULL
+27
IME.AX
$20M
ImExHS Limited
LEAN BULL
+16
MVF.AX
$290M
Monash IVF Group Limited
BEARISH
-43
MAP.AX
$40M
Microba Life Sciences Limited
BEARISH
-58
IIQ.AX
$20M
INOVIQ Ltd
BEARISH
-58
CTE.AX
$60M
Cryosite Limited
BEARISH
-60
HLS.AX
$300M
Healius Limited
BEARISH
-66
IDX.AX
$790M
Integral Diagnostics Limited
BEARISH
-75
RHY.AX
$30M
Rhythm Biosciences Limited
BEARISH
-91
IBX.AX
$10M
Imagion Biosystems Limited
BEARISH
-91
SHL.AX
$9.2B
Sonic Healthcare Limited
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| ACL.AX Australian Clinical Labs Limited | $520M | 22.7 | 34.3 | 47.4 | 4.9 | 5.8 | 5 | BULLISH | 6.9 |
| BDX.AX BCAL Diagnostics Limited | $30M | -4.5 | -376.5 | -270.7 | -2469.1 | -36.7 | 1 | BULLISH | 33.9 |
| GSS.AX Genetic Signatures Limited | $20M | -1.3 | -70.5 | -190.7 | -132.4 | 13.7 | 5 | LEAN BULL | -72.8 |
| IME.AX ImExHS Limited | $20M | 92.9 | -24.3 | 4.9 | 0.4 | 39.8 | 6 | LEAN BULL | 44.4 |
| MVF.AX Monash IVF Group Limited | $290M | 39.3 | 13.2 | 10.3 | 0.2 | 15.5 | 7 | BEARISH | 5.0 |
| MAP.AX Microba Life Sciences Limited | $40M | -1.4 | -108.7 | -150.5 | -136.7 | 73.8 | 2 | BEARISH | -42.4 |
| IIQ.AX INOVIQ Ltd | $20M | -3.0 | -74.3 | -162.9 | -1751.7 | 140.6 | 6 | BEARISH | -57.5 |
| CTE.AX Cryosite Limited | $60M | 25.1 | 130.8 | 39.7 | 13.0 | 25.5 | 5 | BEARISH | 43.8 |
| HLS.AX Healius Limited | $300M | -0.7 | -93.5 | 2.2 | -56.2 | -21.3 | 5 | BEARISH | -53.5 |
| IDX.AX Integral Diagnostics Limited | $790M | 36.4 | 5.4 | 8.1 | 3.3 | 55.6 | 6 | BEARISH | -24.6 |
| RHY.AX Rhythm Biosciences Limited | $30M | -4.5 | -433.3 | -1999.7 | -9395.5 | -54.5 | 4 | BEARISH | -12.1 |
| IBX.AX Imagion Biosystems Limited | $10M | -0.6 | 157.2 | 396.0 | — | -68.7 | 3 | BEARISH | -58.8 |
| SHL.AX Sonic Healthcare Limited | $9.2B | 15.1 | 13.8 | 22.2 | 6.2 | 21.8 | 4 | BEARISH | -19.8 |
| ACL.AX Australian Clinical Labs Limited | $520M | 22.7 | 34.3 | 47.4 | 4.9 | 5.8 | 5 | BULLISH | 6.9 |
| BDX.AX BCAL Diagnostics Limited | $30M | -4.5 | -376.5 | -270.7 | -2469.1 | -36.7 | 1 | BULLISH | 33.9 |
| GSS.AX Genetic Signatures Limited | $20M | -1.3 | -70.5 | -190.7 | -132.4 | 13.7 | 5 | LEAN BULL | -72.8 |
| IME.AX ImExHS Limited | $20M | 92.9 | -24.3 | 4.9 | 0.4 | 39.8 | 6 | LEAN BULL | 44.4 |
| MVF.AX Monash IVF Group Limited | $290M | 39.3 | 13.2 | 10.3 | 0.2 | 15.5 | 7 | BEARISH | 5.0 |
| MAP.AX Microba Life Sciences Limited | $40M | -1.4 | -108.7 | -150.5 | -136.7 | 73.8 | 2 | BEARISH | -42.4 |
| IIQ.AX INOVIQ Ltd | $20M | -3.0 | -74.3 | -162.9 | -1751.7 | 140.6 | 6 | BEARISH | -57.5 |
| CTE.AX Cryosite Limited | $60M | 25.1 | 130.8 | 39.7 | 13.0 | 25.5 | 5 | BEARISH | 43.8 |
| HLS.AX Healius Limited | $300M | -0.7 | -93.5 | 2.2 | -56.2 | -21.3 | 5 | BEARISH | -53.5 |
| IDX.AX Integral Diagnostics Limited | $790M | 36.4 | 5.4 | 8.1 | 3.3 | 55.6 | 6 | BEARISH | -24.6 |
| RHY.AX Rhythm Biosciences Limited | $30M | -4.5 | -433.3 | -1999.7 | -9395.5 | -54.5 | 4 | BEARISH | -12.1 |
| IBX.AX Imagion Biosystems Limited | $10M | -0.6 | 157.2 | 396.0 | — | -68.7 | 3 | BEARISH | -58.8 |
| SHL.AX Sonic Healthcare Limited | $9.2B | 15.1 | 13.8 | 22.2 | 6.2 | 21.8 | 4 | BEARISH | -19.8 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
ACL.AX vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F